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Abstract The increasing rate of injuries to the meniscus in-
dicates the urgent need to develop effective repair strategies.
Irreparably damaged menisci can be replaced and meniscus
allografts represent the treatment of choice; however, they
have several limitations, including availability and compati-
bility. Another approach is the use of artificial implants but
their chondroprotective activities are still not proved clinically.
In this situation, tissue engineering offers alternative natural
decellularized extracellular matrix (ECM) scaffolds, which
have shown biomechanical properties comparable to those
of native menisci and are characterized by low immunogenic-
ity and promising regenerative potential. In this article, we
present an overview of meniscus decellularization methods
and discuss their relative merits. In addition, we comparative-
ly evaluate cell types used to repopulate decellularized scaf-
folds and analyze the biocompatibility of the existing experi-
mental models. At present, acellular ECM hydrogels, as well
as slices and powders, have been explored, which seems to be
promising for partial meniscus regeneration. However, their
inferior biomechanical properties (compressive and tensile
stiffness) compared to natural menisci should be improved.
Although an optimal decellularized meniscus scaffold still
needs to be developed and thoroughly validated for its regen-
erative potential in vivo, we believe that decellularized ECM
scaffolds are the future biomaterials for successful structural
and functional replacement of menisci.
Keywords Meniscus . Decellularization . Biomechanical
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Introduction
The meniscus of the knee consists in two semilunar (C-
shaped) fibrocartilage structures located at the medial and lat-
eral articular surfaces of the tibial plateau. Some of the func-
tions performed by the meniscus are stabilization, nourish-
ment and force distribution in the knee joint. A normal human
meniscus consists of 72% water, 22% collagen and 0.8% gly-
cosaminoglycans (GAGs), which act as lubricants in the joint
(Tan and Cooper-White 2011).
Tears of the meniscus often take place during sporting
events or heavy lifting and can lead to motor dysfunction.
Among the 1,500,000 arthroscopic knee surgeries performed
annually in the United States, around 50% are related to the
meniscus (Kheir et al. 2011). Injuries of the knee meniscus are
a serious medical problem, because tears in the inner avascular
zone of the meniscus usually do not heal spontaneously and
ultimately lead to permanent degenerative changes. This issue
is addressed by partial or total meniscectomy developed by
Gillquist et al. in 1982 (Gillquist et al. 1982), which is cur-
rently a principal therapeutic approach; however, it inevitably
results in the destruction of the normal meniscus structure,
presenting a high risk of osteoarthritis (Hoben and
Athanasiou 2006). As an alternative to meniscectomy,
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allogeneic menisci have been used to replace the impaired
structures but they carry the risk of inducing immunoreactivity
together with unfavorable prognosis (Rath et al. 2001).
Synthetic and biological materials such as the collagen me-
niscus implants (Stone et al. 1992, 1997), polyurethane me-
niscus implants (Verdonk et al. 2011), silk fibrous protein
scaffolds (Mandal et al. 2011a), polycaprolactone scaffolds
(Baker et al. 2010, 2012) and polyester–carbon cell-free im-
plants (Wood et al. 1990) have been used to simulate the
architecture and function of the meniscus (Scotti et al.
2013). Research activity in this direction is reflected in recent
publications (Fig. 1). The difference between these materials
and natural menisci lies in completely different organization
and interactions among the major tissue constituents: water,
GAGs and collagen. For example, coarse and circumferential
collagen type I, which constitutes 98% of meniscal collagen,
has a characteristic organization and orientation in the natural
menisci and gives the tissue great tensile stiffness and strength
(Fithian et al. 1990). Since the natural meniscus has such a
complex three-dimensional structure and unique biomechani-
cal properties as well as biological characteristics, the optimal
biomaterials for the meniscus replacement still need to be
developed.
Nowadays, decellularized ECM scaffolds are increasingly
investigated as a natural replacement of the injured meniscus,
which would facilitate its regeneration. Decellularized ECM is
prepared by removing cells and their components from allo-
geneic or xenogeneic donor tissues to produce a minimally
immunogenic scaffold with required biomechanical and bio-
logical properties (Crapo et al. 2011). Cells are lysed using
physical (e.g., shocks and freeze–thaw cycles), chemical (e.g.,
detergents such as Triton X-100 and SDS) and enzymatic
(e.g., DNase and trypsin) treatments that disrupt and solubilize
both the cytoplasmic and nuclear membranes of the cell
(Fig. 2). The obtained decellularized scaffolds are then used
to replace damaged menisci in the knee joint where they will
interact with the biological environment by promoting cell
infiltration and production of the ECM. As a result, they
should integrate with the surrounding tissue. Thus, the general
procedure of meniscus regeneration using natural ECM scaf-
folds includes three steps: decellularization of donor tissue
ECM, repopulation with appropriate cells and implantation,
i.e., remodeling and repair of the degenerated meniscus
(Fig. 3).
Cur ren t ly, a var ie ty of dece l lu la r iza t ion and
recellularization protocols used in meniscus replacement have
been reported but there is no consensus on the optimal proce-
dure to generate decellularized menisci or their application.
This review summarizes recent advances in the research on
meniscal decellularization and recellularization during the
production of ECM scaffolds, which may help to create an
optimal protocol and establish the strategy to be used for suc-
cessful replacement and repair of injured menisci.
Comparison of different therapeutic measures
In view of the limited healing capacity of meniscal injuries,
the preservation, repair, reconstitution and replacement of
meniscal tissues are indispensable. For many years, partial
and total meniscectomy remained the most commonly per-
formed orthopedic surgeries (Stabile et al. 2010) but they have
several drawbacks. Natural menisci could dissipate part of the
load to the chondral surface and reduce biomechanical wear;
in addition, the knee stability depends on the integrity of me-
nisci. Furthermore, meniscal injuries may induce inflammato-
ry responses and degenerative processes (Kaleka et al. 2014).
Therefore, efforts are focused on meniscal preservation;
however, not all meniscal tears are reparable and meniscus
allograft transplantation is widely applied. The types of allo-
grafts used include fresh, deep-frozen, freeze-dried and cryo-
preserved (frozen in cell-preserving solution) (Stabile et al.
2010). Among them, long-term freezing and freeze-drying
could destroy viable cells and denature histocompatibility an-
tigens (Arnoczky et al. 1988). An allograft meniscus typically
shows invasion of blood vessels and complete healing in the
periphery, together with the presence of fibrochondrocytes
throughout the meniscus; however, more than 50%
(P < 0.05) reduction in the number of fibrochondrocytes has
been commonly observed (Rath et al. 2001). Even after freez-
ing, meniscal allograft transplants are potentially immunogen-
ic, resulting in even higher post-transplantation failure rate
compared to fresh grafts (Siegel and Roberts 1993; Verdonk
et al. 2005). In addition, the high cost of tissue grafts, necessity
of surgical precision and the risk of bacterial contamination
impose restrictions on the clinical application (Kaleka et al.
2014).
Among the newly developed tissue engineering scaffolds,
the collagen meniscus implant (CMI), first developed for clin-
ical use in the United States (Stone et al. 1990), seems to be
Fig. 1 Increase in the number of publications related to meniscus
engineering. Papers published from 1989 to 2015 were searched in
PubMed using a key word Bmeniscal engineering^
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Fig. 2 A Normal meniscus;
normal human meniscus is
composed of 72% water, 22%
collagen and 0.8%
glycosaminoglycans (GAGs)
(Tan and Cooper-White 2011). B
Meniscus after physical treatment
(e.g., freeze–thaw cycles); formed
intracellular ice crystals disrupt
cellular membranes, causing cell
lysis. CMeniscus after chemical
treatment (e.g., ionic detergent);
significant removal of nuclear
debris and cytoplasmic proteins;
however, adverse effects such as
destruction of GAGs and collagen
are also prominent. DMeniscus
after enzymatic treatment (e.g.,
DNase); considerable DNA deg-
radation and removal of ECM
components
Fig. 3 Fabrication of a cell-
seeded meniscal scaffold
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the best. Its advantages include low immunogenicity, induc-
tion of tissue regeneration, adaptable pore size and remodeling
capacity of ingrown tissue (Scotti et al. 2013); nevertheless, it
has a reoperation rate of 22% and a considerable degradation
rate of the scaffold (from 6 months to 2 years) (Scotti et al.
2013). In addition, its inferior biomechanical properties (com-
pressive and tensile stiffness) compared to native meniscus
make the load distribution in the knee minimal or absent
(Buma et al. 2007).
Under such circumstances, many researchers have focused
on the development and application of decellularization tech-
nologies. A number of acellular scaffolds and related
decellularization protocols have received regulatory approval
for clinical use, such as human dermis (Chen et al. 2004),
blood vessels (Dahl et al. 2003; Uchimura et al. 2003) and
porcine heart valves (Bader et al. 1998). Decellularization has
shown its particular advantages in regard to minimization of
immunogenicity and preservation of the ECM, which is es-
sential for the regeneration of organic injuries (Song and Ott
2011). The ECM secreted by resident cells of each tissue has
been confirmed to provide cues affecting cell migration, pro-
liferation, differentiation and host tissue remodeling (Crapo
et al. 2011; Valentin et al. 2010; Xu et al. 2010). A good
meniscus ECM scaffolds should maintain the three-
dimensional structure and composition of the ECM. Unlike
the CMI, the ECM scaffold which act as a frame for tissue
regeneration by endogenous cells, would be effective in
retaining the mechanical properties (compressive stress and
tensile stiffness) of natural menisci (Buma et al. 2007;
Sandmann et al. 2009; Stabile et al. 2010); as a result, biolog-
ical functions could be preserved after transplantation. Indeed,
after decellularization, residual cellular components could ne-
gate tissue remodeling of biologic scaffolds in vivo (Brown
et al. 2009; Zhang et al. 2010). Therefore, tissue processing
methods, including decellularization and recellularization, are
pivotal for clinical success.
Current protocols of meniscus decellularization
In 2005, Yamasaki et al. (2005) conducted the first in vitro
study with the aim to resolve the problems of biomechanical
failure, cellular toxicity and immunological reactivity report-
ed for allogeneic transplants. In their study, awrat menisci
were treated with Na-EDTA and ethanol for 3 days and
freeze–thawed three times using liquid nitrogen to destroy
meniscus chondrocytes; the prepared scaffolds had the poten-
tial for cellular repopulation with adequate stiffness. However,
the procedure did not result in complete decellularization be-
cause allogeneic cells and their components could not be
washed out and, consequently, could elicit severe immune
response.
In 2007, Maier et al. (2007) investigated decellularized
ovine menisci. Ovine meniscus tissues were incubated at
37 °C with agitation (120 rpm) in enzymatic solution contain-
ing 0.25% trypsin, 3 mg collagenase A (specific activity >
0.15 U/mg), 0.375 mg/ml protease and 0.02% EDTA.
Histological and immunohistochemical analyses indicated
complete cell removal and the absence of histocompatibility
complex (MHC) I or II expression. In addition, the scaffolds
had a loose structure with gaps and micropores (approximate-
ly 5–25 mm), indicating the ability of collagenase to create
micropores in tissues at low concentrations. However, GAGs,
which play a pivotal role in the regulation of water content
within the meniscus, were partially removed (P < 0.01) and
the disruption and partial digestion of the ECM was
significant.
In 2008, Stapleton et al. (2008) published a study on the
decellularization of porcine menisci that were first subjected
to three dry freeze–thaw cycles for cell lysis and then incubat-
ed in hypotonic (10 mM Tris-HCl) buffer with 0.1% ionic
detergent (SDS) for 48 h to solubilize cellular fragments and
finally with DNase and RNase to digest nucleic acids.
Nevertheless, H&E staining indicated cell presence, although
cell density decreased with the distance from the vascularized
region of the meniscus and there was a 59.4% loss of GAG
content (P < 0.05). However, no significant decrease in the
content of collagen (P > 0.05), which is responsible for the
well-preserved tensile properties of the meniscal tissue, was
observed (Aspden et al. 1985; Courtman et al. 1994). The
decellularized scaffolds retained the tensile properties of the
natural meniscus, were not cytotoxic and demonstrated good
biocompatibility (Stapleton et al. 2011).
In 2009, Sandmann et al. (2009) published a study on the
generation and characterization of acellular human meniscus
scaffolds. In their protocol, menisci were incubated for differ-
ent time periods (1 and 2 weeks) in solutions containing var-
ious concentrations of SDS (1, 2 and 5%). Complete cell re-
moval was achieved in 2% SDS after 2 weeks without
compromising compressive properties. Indeed, SDS and other
detergents such as Triton X-100 could remove cells complete-
ly but SDS was more efficient in cell lysis than Triton X-100;
however, the former was observed to cause extreme fragmen-
tation and swelling of collagen fibers and was less supportive
of cell reseeding of the scaffolds (Bodnar et al. 1986;
Courtman et al. 1994). Thus, it is necessary to evaluate the
in vivo performance of the scaffold.
In 2013, Azhim et al. (2013) developed a novel
decellularization approach based on sonication. Bovine me-
nisci were cut into fragments (10 × 10 × 5 mm) and sonicated
in constantly circulating 0.1% SDS solution for 10 h in a
reactor. Since sonication facilitated the penetration of SDS
solution inside the samples, almost all cell nuclei could be
removed by the treatment, which was superior to the immer-
sion method used in the control group. The disadvantage was
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that sonication caused GAG denaturation resulting in a de-
crease in water content and mechanical strength.
In 2010, Stabile et al. (2010) investigated a procedure to
obtain acellular allograft-derived scaffolds from ovine menis-
ci, which was previously applied to tendon tissue (Whitlock
et al. 2007). Ovine menisci were incubated in solution con-
taining 0.05% trypsin-EDTA, 2% Triton X-100 and 1.5%
peracetic acid for 48 h to remove cellular debris and nuclear
components and increase tissue porosity. Histological analysis
revealed the absence of nuclei in the scaffold and a 55% de-
crease in DNA content compared to the native menisci
(P < 0.003). The authors suggested that residual DNAwould
not promote immune response but other cellular components
might (Khoury et al. 1994; Rodeo et al. 2000). To analyze
biocompatibility, the scaffolds and latex specimens, a positive
control for cytotoxicity testing, were cultured on subconfluent
monolayers of murine embryonic fibroblasts (NIH 3T3 cells)
and analyzed for the viability and proliferation of infiltrating
cells. More cells populated the scaffolds compared to latex
structures, indicating lower cellular toxicity. Scanning elec-
tron microscopy (SEM) showed that pore connectivity of the
ECM scaffolds increased from 41 to 87% (P < 0.01), revealing
overall elongation of pathways for cell migration into the
graft. However, the ideal pore size and connectivity for the
biological integration of scaffolds into meniscal tissue remains
unknown.
In 2011, Yu et al. (2011) reported another protocol to pre-
pare decellularized scaffolds from rabbit menisci. Tissues
were incubated in hydrogen peroxide for 1 h, 6% Triton X-
100 for 24 h, 6% sodium deoxycholate for 24 h and 3% Triton
X-100 for 24 h. Histological analysis indicated complete cell
removal and retention of intact collagen type I.
In 2015, Chen et al. (2015) developed an acid-based
decellularization method for porcine menisci, which were
treated with acetic, formic, 15% peracetic, 60% malic,
succinic, or 60% citric acids and freeze-dried to fabricate the
scaffold. The treatment with formic acid decreased DNA con-
tent to 4.10 ± 0.03% after 2 h (P < 0.001) and to 0.40 ± 0.02%
after 12 h, while that with acetic, peracetic, malic and citric
acids caused a less significant reduction after 2 h, indicating
effective decellularization with formic acid. Although formic
acid reduced collagen content to 37.09 ± 0.29% (P = 0.011)
after 12 h, it produced no adverse effect on either GAGs or
collagen after 2 h while providing complete cell removal and,
thus, was superior to other acids. The porosity of the acellular
ECM scaffold was 85.76 ± 2.80% and no cytotoxicity was
observed.
Wu et al. (2015) attempted to convert solid meniscus ECM
scaffolds into injectable hydrogel. Porcine menisci were cut
into 1-mm slices, frozen at 80 °C, powdered, stirred in 1%
SDS in PBS for 72 h and treated with 0.1% EDTA in PBS for
24 h. To prepare the injectable hydrogel, the decellularized
meniscus matrix ground to fine powder was suspended in
pepsin/0.01 M HCl solution at 15 mg/mL, injected into a
cylinder mold and placed in a 37 °C incubator for 30 min to
form solidified hydrogel. The remolded decellularized menis-
cus presented a pink matrix without visible nuclear dots by
H&E and DAPI staining and had a collagen content of 78 ±
22% (dry weight), which was higher than that in the native
meniscal tissue (42 ± 10%). Nevertheless, the GAG content
significantly decreased from 14.95 ± 5.57 μg/mg to 0.54 ±
0.08 μg/mg.
Maintenance of biomechanical properties
Amajor consideration in the preparation and evaluation of the
ECM scaffolds for meniscal repair and replacement is the
preservation and restoration of the mechanical function.
Biomechanical factors play a pivotal role in the design and
synthesis of tissue-engineered biomaterials and are also im-
portant for evaluating the efficacy of restoring normal
meniscal function (Setton et al. 1999). The microstructure of
the meniscus is optimal for load support in the knee and a high
density of collagen fiber bundles (primarily type I collagen)
allow the sustaining of the tensile stress generated during
functional loading (Aspden et al. 1985; Bullough et al. 1970).
Among biomechanical properties, the most important is
viscoelasticity characterized by three important parameters:
compressibility, relaxation and stiffness (Maier et al. 2007),
measured by cyclic compression–relaxation tests. Briefly, the
sample is preloaded and compressed dynamically with con-
stant velocity, then compressed statically and relaxed with
constant velocity. The Bcompressibility^ is defined as the
end of the dynamic compression phase, while the Bresidual
force^ is defined as the end of the static compression phase
and the Bstiffness^ is calculated from the linear-elastic slope of
loading (Maier et al. 2007).
After the enzymatic digestion process conducted by Maier
et al. (2007), GAG extraction changed the structure of the
ECM, increasing compressive stiffness and compressibility
and slightly decreasing the residual force. The results were
quite similar to those obtained by Azhim et al. (2013), who
also detected GAG denaturation after sonication. The extrac-
tion of GAGs resulted in the loss of water (Schmidt et al.
1990; Zhu et al. 1993) and thus contributing to the increase
of stiffness, which was described by Maier et al. (2007).
Abdelgaied et al. (2015) followed the same protocol devel-
oped by Stapleton et al. (2008) to compare tensile and com-
pressive properties of decellularized and normal porcine me-
nisci. The decellularized menisci showed lower compressive
elastic modulus and higher compressive permeability com-
pared to the natural structure, which could be attributed to a
60% loss of GAG content.
On the other hand, Sandmann et al. (2009) characterized
their scaffold and verified preservation of the compressive
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properties. Thus, it can be suggested that SDS would not de-
stroy GAGs to the same extent as sonication and enzymatic
digestion. Stabile et al. (2010) also confirmed the successful
maintenance of the compressive and tensile biomechanical
properties in the meniscus scaffold they created. It can be
concluded that the chemical reagents such as Triton X-100
and 1.5% peracetic acid used in their protocol may present
milder and more effective treatment to retain the microstruc-
ture of menisci.
In the future, in-depth investigation of full meniscus ECM
scaffolds in animal models is essential, since the ultimate goal
is to test biological and physical functions of the scaffolds
in vivo.
Potential source of cells for the recellularization
of meniscus ECM scaffolds
Meniscal tissue contains fibroblast-like cells located at the
outer vascular region and round fibrochondrocytes inter-
spersed within the middle and inner regions (Hasan et al.
2014; Rongen et al. 2014).
In tissue engineering, several types of cells have been used
for recellularization of artificial and natural biological scaf-
folds. Cell-seeded constructs offer potential advantages by
enhancing the integration of scaffolds with native tissues and
providing a specific cellular microenvironment to promote
required cellular activities, including ECM production, cell
proliferation and activation of cell signaling pathways. In
decellularized menisci, ideal cells for recellularization should
be minimally immunogenic, easily obtainable and able to gen-
erate the native ECM.
Although meniscal fibrochondrocytes are the most com-
mon cells in the meniscus and are easy to extract, their prolif-
erative capacity in humans decreases dramatically with age
(Barbero et al. 2004). In an early study on scaffold
recellularization, fibrochondrocytes were seeded on
polyglycolic acid structures and implanted into nude mice
(Ibarra et al. 1997). At first, only granulation tissue was
formed, while histologically fibrocartilaginous tissue was de-
veloped later. However, the production of the ECM remained
a challenge.
In the first study on recellularization of decellularized me-
niscus scaffolds, Maier et al. (2007) seeded autologous
fibrochondrocytes onto ovine meniscus scaffolds using a man-
ual needle injection technique. Cells survived and proliferated
for over 28 days, demonstrating the feasibility of culturing
cells within ECM scaffolds. It was the first study to seed
meniscal cells into an allogeneic meniscus scaffold that sur-
vived for such a long time. However, cell differentiation and
ECM production were not investigated.
In another study, decellularized ECM scaffolds were seed-
ed with human primary chondrocytes, which were dropped
directly into the scaffolds using a pipette (Chen et al. 2015).
To measure DNA, GAGs and total collagen contents, samples
were digested with papain. Chondrocytes were cultured on the
scaffold for 7, 14, 21 and 28 days and DNA content began to
show 1.03-, 1.89- and 2.62-fold increases, respectively, after
14, 21 and 28 days. In addition, cell numbers increased 10.1-
fold over 28 days. Total collagen content was assessed by acid
hydrolysis and treatment with chloramine-T and p-
dimethylaminobenzaldehyde in papain-digested samples to
determine hydroxyproline, which was converted to total col-
lagen using a mass ratio of 7.25 (Pal et al. 1981). GAGs, total
collagen and type II collagen synthesis by scaffold-seeded
cells increased by 572.34%, 301.11% and 191.79% from
day 7 to day 21, respectively. However, the content of type I
collagen was below the detection limit [lower limit of quanti-
fication (LLOQ) < 0.08 μg/mL]. These data indicated the de-
position and de novo synthesis of GAGs, total collagen and
type II collagen by chondrocytes cultured on acellular ECM
scaffolds. The results were in agreement with another study
showing that auricular chondrocytes may have a greater ca-
pacity for the synthesis of type II collagen and GAGs than
fibrochondrocytes (Hoben et al. 2007). Since the meniscus
contains approximately 98% type I collagen (Sun et al.
2012), it can be suggested that auricular cartilage may not be
an optimal cell source for meniscus acellular scaffolds.
In addition, mesenchymal stem cells (MSCs), which have
been proved to function as pluripotent cell progenitors, may
be a good choice for cartilage regeneration (Arnoczky 1999;
Wakitani et al. 1994). Yamasaki et al. (2008) reported that
bone marrow-derived MSCs seeded on the scaffolds showed
a chondroprotective effect in a rat model. When human
(h)MSCs were cultured with 3D aqueous silk-derived scaf-
folds fabricated by salt-leaching and freeze-drying to mimic
native meniscus pore heterogeneity (Mandal et al. 2011a),
they demonstrated a significant upregulation of cartilage-
related ECM markers such as collagen type I, aggrecan and
SOX-9 (Mandal et al. 2011b). Another study indicated that
mature meniscal cells cultured with hMSCs at a 3:1 ratio
showed higher expression of collagen type I and GAGs and
lower levels of hypertrophic biomarkers such as collagen X
and MMP13, demonstrating a more pronounced meniscal
phenotype compared to pure hMSC cultures (Cui et al. 2012).
Dermal fibroblasts could also be chosen for differentiation
to fibrochondrocytes. Indeed, the transfection with the genes
encoding SOX proteins 5, 6 and 9, co-culture with
demineralized bone powder and growth on aggrecan- or
perlecan-coated surfaces have been proved to upregulate col-
lagen II and GAG synthesis in fibroblasts (French et al. 2002,
2004; Ikeda et al. 2004, Mizuno and Glowacki 1996).
Stapleton et al. (2011) incubated porcine medial meniscal
cells (PMMCs) and human dermal fibroblasts (PHDFs) on
decellularized meniscus scaffolds. The approximate confluent
cell density (CCD) was 4 × 103 cells/cm2 for PHDFs and 6 ×
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103 cells/cm2 for PMMCs. PHDFs seeded at the CCD showed
limited attachment and some of the adhered cells were not
fully spread on the tissue surface as evidenced by SEM anal-
ysis. At the seeding density of 10 × CCD, cellular attachment
was improved and at 100 × CCD, cells formed a complete
monolayer across the tissue surface. However, no cell infiltra-
tion into the inner compartments of the acellular scaffold was
detected after 24 h. PMMCs seeded at the CCD showed at-
tachment to the scaffolds and the majority of cells exhibited
flattened morphology; however, infiltration was also not
observed.
These decellularized meniscus scaffolds failed to be
recellularized as full-thickness menisci partially because of
their dense structure. Wu et al. (2015) seeded primary bovine
chondrocytes isolated from knee joints of calves on the sur-
face of meniscus-derived ECM hydrogel together with fibro-
blasts. At day 14, 21 ± 4% of chondrocytes were observed in a
1200–1500-μm zone as shown by DAPI labeling, where they
demonstrated even distribution, round morphology and posi-
tive SOX9 staining. In addition, the hydrogel showed good
tissue compatibility in vivo.
In vivo immunobiocompatibility
The rejection of animal tissues transplanted to humans mostly
occurs due to hyperimmunoreactivity of the host towards the
scaffold or its degradation products, which may be mediated
by MHC class I and II. Maier et al. (2007) conducted immu-
nohistochemistry analysis of MHC before and after meniscus
processing. Specific positive reactivity was observed for sy-
novial and endothelial cells (MHC II) and fibrochondrocytes
(MHC I) in the native meniscus, while none was observed
after decellularization.
Furthermore, antibodies against galactose-α-1,3-galactose
(α-Gal) and continuous antigenic cross-reaction with gastro-
intestinal bacteria (Galili 2001) may also cause hyperimmune
rejection. Therefore, it is important to ensure the removal ofα-
Gal epitopes from the meniscus intended for clinical applica-
tion. To determine the residual α-Gal content after
decellularization, Stapleton et al. (2008) used α-galactosyl
transferase-deficient GTKOmice, demonstrating more signif-
icant immunoreactivity against the α-Gal epitopes abundant
in menisci. Mice were immunized or not with porcine blood
cells and were implanted subcutaneously with fresh,
decellularized, or decellularized α-galactosidase-treated
meniscal tissues. As a result, mice demonstrated 240, 480
and 1260 antibody units to fresh, decellularized and α-
galactosidase-treated menisci, respectively, suggesting the re-
moval of α-Gal epitopes through decellularization.
Immunohistochemistry revealed no signs of immunoreactivity
in decellularized scaffolds. The scaffolds tended to be acellu-
lar in the center, while the periphery of the explants was
populated mostly with fibroblast-like cells. The explants were
surrounded by fibrous capsules containing mononuclear cells,
which were thicker than the untreated nativemenisci. The data
suggested that in vitro recellularization before implantation
may result in a loss of the donor cells after implantation, which
was consistent with the results of another study (Jackson et al.
1993). Therefore, the in vivo recellularization approaches may
need to be developed (Ionescu and Mauck 2013).
Chen et al. (2015) evaluated the immunocompatibility of
decellularized ECM scaffolds in rats. The scaffolds were im-
planted dorsally into four subcutaneous pockets and analyzed
for inflammatory reactions on days 7, 14 and 28 post-implan-
tation. In contrast to native implants, no signs of inflammation
were observed for decellularized scaffolds that were absorbed
at day 28, indicating that the decellularization of allogeneic
menisci could significantly reduce immune reactivity in vivo.
In another study, surgical trauma was minimized by a sub-
cutaneous injection of meniscus-derived ECM hydrogel that
was solidified into stable opaque hydrogel 30 min after im-
plantation (Wu et al. 2015). Over the next week, the formed
hydrogel decreased in volume and was infiltrated by
granulocytes and macrophages; at day 3, cell percentage in
the 200- to 300-μm zone increased from 4 ± 1% to 27 ± 9%.
No apparent angiogenesis was observed in the tissue sur-
rounding the scaffold.
Discussion
Menisci from rats, sheep, pigs and humans could be
decellularized using a variety of methods, including physical
(freezing–thawing, sonication), chemical (detergents such as
SDS, peracetic acid and Triton X-100; EDTA, hypotonic
buffers), biological (enzymatic digestion) and their combina-
tions (Fig. 4).
Methods such as freezing–thawing and incubation with
detergents or hypotonic buffers (Tris-HCl) can be used for cell
lysis without significant adverse effects on the meniscal ECM
(Stapleton et al. 2008). Sonication and detergents can also
destroy the nuclei, which may be an advantage (Gilbert et al.
2006). The treatment with collagenase can create micropores
within menisci but at the same time may denature GAGs
(Maier et al. 2007). Although SDS has been proved to effec-
tively remove cells while retaining collagen fibers, it separates
GAGs from proteins in the ECM and residual SDS presence
may have adverse effects on cell growth and tissue regenera-
tion (Wu et al. 2015). Therefore, the time of SDS treatment
should be reduced and milder detergents should be considered
for meniscus decellularization to ensure GAG retention.
Similarly, sonication may also cause GAG denaturation
(Azhim et al. 2013), while formic acid, which was proved to
be effective in decreasing DNA content, may destruct colla-
gen (Chen et al. 2015). According to previous studies on
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meniscal decellularization, tensile properties are mostly attrib-
uted to collagen fibers, while compressive properties are most-
ly associated with GAGs (Abdelgaied et al. 2015; Maier et al.
2007; Schmidt et al. 1990; Zhu et al. 1993). In addition, GAGs
colocalized with type II collagen could maintain viscoelastic
properties, compression stiffness and tissue hydration (Buma
et al. 2007), while a 1% decrease in GAG content could result
in a 1.1% decrease in elasticity (Zwierzchowski et al. 2015).
Since meniscal biomechanical properties are closely related to
the structure and organization of the collagen network and
GAG content, the ECM retaining these components after
decellularization would, at the same time, possess favorable
biomechanical characteristics.
Among all investigated protocols, 2% SDS treatment of
whole human menisci for 2 weeks preserved compressive
properties (Sandmann et al. 2009), while 2% Triton X-100
and 1.5% peracetic acid treatment of whole ovine menisci
for 48 h preserved both compressive and tensile characteristics
(Stabile et al. 2010) and collagenase and protease treatment of
whole ovine menisci resulted in the increase of compressive
stiffness and compressibility (Maier et al. 2007). As for partial
meniscal decellularization, bovine menisci processed by son-
ication also increased compressive stiffness and compressibil-
ity (Azhim et al. 2013), while porcine menisci incubated in
0.1% SDS for 2 days showed a decrease in compressive mod-
ulus and an increase in compressive permeability (Abdelgaied
Fig. 4 Current decellularization strategies for the meniscus
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et al. 2015) (Fig. 4). Thus, it can be suggested that enzymatic
digestion and sonication as well as SDS processing may in-
fluence the biomechanical features of decellularized menisci.
Regarding the recellularization of ECM scaffolds,
several cell types have been investigated, including
fibrochondrocytes, primary chondrocytes, MSCs and fibro-
blasts (Fig. 5). Among them, fibrochondrocytes have been
proved to dramatically decrease their proliferative capacity
with donor age. Chondrocytes and fibroblasts have been ap-
plied to assess cellular compatibility of the scaffolds (Peretti
et al. 2001, 2004). In addition, bone-marrow (BM)-derived
MSCs have been suggested as an excellent cell type for seeding
into acellular meniscus scaffolds (Yamasaki et al. 2008).
BM-MSCs showed a good infiltration rate and expressed
specific ECM components. In addition, hMSCs have also been
a good choice to study the ability of scaffolds to promote
chondrogenic differentiation and increase the expression of
genes encoding aggrecan and type II collagen. Co-culture of
meniscal cells with hMSCs at a 3:1 ratio promoted the highest
synthesis of molecules essential for the maintenance of menis-
cus integrity (Cui et al. 2012). However, long-term evaluation
of the transplanted tissues is required to validate the clinical
potential of BM-MSC-seeded scaffolds.
Most studies have indicated that the ECM scaffolds have
good immunocompatibility with recipient tissues due to com-
plete removal of donor cells (Chen et al. 2015; Stapleton et al.
2011). However, the ECM of meniscal tissues has a thick and
dense fibrous structure (Stapleton et al. 2008), which may be a
Fig. 5 Cell sources for recellularization
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problem for cell infiltration into the inner region of the im-
planted scaffolds. The solution for this problem may be pro-
cessing acellular scaffolds into hydrogels, which results in
increased porosity within the implanted material and rapid cell
infiltration (Wu et al. 2015). Thus, decellularized meniscal
tissues with low immunogenicity and improved porosity, such
as meniscal slices, powders and hydrogels could be more ef-
fective in regard to recellularization comparedwith intact acel-
lular meniscal scaffolds. However, the processed
decellularized ECM scaffolds may have a disadvantage of
losing biomechanical properties of the native structure, such
as stress and tension resistance, which could in turn affect
cellular behavior and metabolic activity in vivo; therefore,
their application may be limited to partial meniscus regenera-
tion. Further studies should be conducted to investigate the
regenerative capacity of processed ECM scaffolds in vivo
and their applicability to the repair of partial defects in
menisci.
In conclusion, the decellularized meniscus scaffolds have
demonstrated good biocompatibility, biomechanical charac-
teristics and regenerative properties and present a promising
approach to the functional restoration of injured menisci.
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